3Penny F Whiting,Marie E Weswood,Anne WS Rutjes,Johannes B Reitsma,Patrick NM Bossuyt,Jos Kleijnen,马章淳,钱楠.QUADAS评价:一种用于诊断性研究的质量评价工具(修订版)[J].中国循证医学杂志,2007,7(7):531-536. 被引量：64
4Gelev S, Spasovski G, Trajkovski Z, et al. Factors associated with various arterial calcifications in haemodialysis patients[J].Prilozi, 2009,29:185-200.
5O' Hare AM, Johansen K. Lower-extremity peripheral arterial disease among patients with end-stage renal disease [J].J Am Soc Nephrol, 2001,12:2838-2847.
6United States Renal Data System: Annual Data Report. Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Division of Kidney, Urologic, and Hematologic Diseases, 2000,339-348.
7Cheung AK, Sarnak MJ, Yan G, et al. htherosclerotic cardiovascular disease risks in chronic hemodialysis patients[]]. Kidney Int, 2000,58: 353-362.
8Kasiske BL, Guijarro C, Massy ZA, et al. Cardiovascular disease after renal transplantation[J]. J Am Soc Nephrol, 1996,7: 158-165.
9Morrissey PE, Shaffer D, Nonaco AP, et al. Peripheral vascular disease after kidney-pancreas transplantation in diabetic patients with end-stage renal disease[J]. Arch Surg, 1997,132:358-361.
10Leskinen Y, Salenius JP, Lehtimaki T, et al. The Prevalence of Peripheral Arterial Disease and Medial Arterial Calci. cation in Patients With Chronic Renal Failure: Requirements for Diagnostics[J]. Am J Kidney Dis, 2002,40: 472-479.
